Australia markets closed

Sun Pharmaceutical Industries Limited (SUNPHARMA.NS)

NSE - NSE Real-time price. Currency in INR
Add to watchlist
1,511.15-7.85 (-0.52%)
At close: 03:30PM IST
Currency in INR

Valuation measures4

Market cap (intra-day) 3.63T
Enterprise value 3.49T
Trailing P/E 40.73
Forward P/E 26.67
PEG ratio (5-yr expected) N/A
Price/sales (ttm)7.77
Price/book (mrq)6.06
Enterprise value/revenue 7.47
Enterprise value/EBITDA 26.13

Trading information

Stock price history

Beta (5Y monthly) 0.53
52-week change 357.11%
S&P500 52-week change 322.38%
52-week high 31,638.85
52-week low 3922.45
50-day moving average 31,566.81
200-day moving average 31,313.11

Share statistics

Avg vol (3-month) 32.75M
Avg vol (10-day) 33.32M
Shares outstanding 52.4B
Implied shares outstanding 62.41B
Float 81.06B
% held by insiders 154.69%
% held by institutions 126.83%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 412.5
Forward annual dividend yield 40.83%
Trailing annual dividend rate 312.50
Trailing annual dividend yield 30.82%
5-year average dividend yield 40.93
Payout ratio 431.00%
Dividend date 3N/A
Ex-dividend date 409 Feb 2024
Last split factor 22:1
Last split date 329 July 2013

Financial highlights

Fiscal year

Fiscal year ends 31 Mar 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 18.77%
Operating margin (ttm)22.05%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)N/A

Income statement

Revenue (ttm)474.45B
Revenue per share (ttm)197.74
Quarterly revenue growth (yoy)10.10%
Gross profit (ttm)N/A
EBITDA 128.15B
Net income avi to common (ttm)89.06B
Diluted EPS (ttm)37.17
Quarterly earnings growth (yoy)16.50%

Balance sheet

Total cash (mrq)148.33B
Total cash per share (mrq)61.71
Total debt (mrq)19.28B
Total debt/equity (mrq)3.05%
Current ratio (mrq)N/A
Book value per share (mrq)249.32

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A